http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1713801-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c76ecadad74a1a35270b3e3a34d60f37
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D453-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D453-02
filingDate 2005-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d55153344fd940b355ed0cbcb1bb5549
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27f4805c6dbed9a632742a38d0102e8f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46f5e0ce25f7580d55fd6c3c6c70dbca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f931528d50f6bdf478d58a16001047a
publicationDate 2006-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1713801-A1
titleOfInvention Process for preparation of 1-(2s,3s)-2-benzhydr yl-n-(5-tert-butyl-2-methoxybenzyl)quinuclidin-3-amine
abstract This invention relates to an improved process for the preparation of (2S,3S)-­ 2-benzhydryl-N-(5-tent-butyl-2-methoxybenzyl)quinuclidin-3-amine, (hereinafter 'compound of Formula I') and its pharmaceutically acceptable salts. In particular, the invention is directed to an improved synthesis of the monohydrate citrate salt of the compound of Formula (la).
priorityDate 2004-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231366226
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18462
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6490877
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393439
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID243096633
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136192772
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7731
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411682
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17905241
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128643247
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71832
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7909
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129026427
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129276926
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1071
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129552165
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10407571
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393605
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231775995
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90745094
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394073
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7504
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7915
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230142550
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129293954
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230136292
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID131278
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40467203
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID204108
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22508564
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6405
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230138508
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID204107
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226481050
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID96403
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128296525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID78926
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128786886
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22230
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127880219
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395748

Total number of triples: 58.